Literature DB >> 30813999

Artificial Lysosomal Platform to Study Nanoparticle Long-term Stability.

Ana MilosevicAc, Joël Bourquin, David Burnand, Philipp Lemal, Federica Crippa, Christophe A Monnier, Laura Rodriguez-Lorenzo, Alke Petri-Fink, Barbara Rothen-Rutishauser.   

Abstract

Nanoparticles (NPs) possess unique properties useful for designing specific functionalities for biomedi- cal applications. A prerequisite of a safe-by-design and effective use in any biomedical application is to study NP-cell interactions to gain a better understanding of cellular consequences upon exposure. Cellular uptake of NPs results mainly in the localization of NPs in the complex environment of lysosomes, a compartment which can be mimicked by artificial lysosomal fluid. In this work we showed the applicability of lysosomal fluid as a platform for a fast assessment of gold, iron oxide and silica NP stability over 24 h in a relevant biological fluid, by using multiple analytical methods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30813999     DOI: 10.2533/chimia.2019.55

Source DB:  PubMed          Journal:  Chimia (Aarau)        ISSN: 0009-4293            Impact factor:   1.509


  3 in total

1.  Transformation of zinc oxide nanoparticles in synthetic lung fluids.

Authors:  Avery C Hatch; Derek Peloquin; Amar S Kumbar; Todd P Luxton; Justin G Clar
Journal:  J Nanopart Res       Date:  2022-07-16       Impact factor: 2.533

2.  Tracking the immune response by MRI using biodegradable and ultrasensitive microprobes.

Authors:  Sara Martinez de Lizarrondo; Charlene Jacqmarcq; Mikael Naveau; Manuel Navarro-Oviedo; Swannie Pedron; Alexandre Adam; Barbara Freis; Stephane Allouche; Didier Goux; Sarah Razafindrakoto; Florence Gazeau; Damien Mertz; Denis Vivien; Thomas Bonnard; Maxime Gauberti
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

3.  Bare Iron Oxide Nanoparticles as Drug Delivery Carrier for the Short Cationic Peptide Lasioglossin.

Authors:  Chiara Turrina; Sonja Berensmeier; Sebastian P Schwaminger
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.